nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Dermatitis atopic—Epirubicin—bone cancer	0.023	0.023	CcSEcCtD
Betahistine—Orthostatic hypotension—Cisplatin—bone cancer	0.022	0.022	CcSEcCtD
Betahistine—Dermatitis atopic—Doxorubicin—bone cancer	0.0213	0.0213	CcSEcCtD
Betahistine—Vasodilation procedure—Epirubicin—bone cancer	0.0194	0.0194	CcSEcCtD
Betahistine—Vasodilation—Epirubicin—bone cancer	0.0194	0.0194	CcSEcCtD
Betahistine—Ventricular extrasystoles—Epirubicin—bone cancer	0.0189	0.0189	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—bone cancer	0.018	0.018	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—bone cancer	0.018	0.018	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.0175	0.0175	CcSEcCtD
Betahistine—Immune system disorder—Cisplatin—bone cancer	0.0151	0.0151	CcSEcCtD
Betahistine—Flatulence—Cisplatin—bone cancer	0.0143	0.0143	CcSEcCtD
Betahistine—Ill-defined disorder—Cisplatin—bone cancer	0.0135	0.0135	CcSEcCtD
Betahistine—Malaise—Cisplatin—bone cancer	0.0131	0.0131	CcSEcCtD
Betahistine—Convulsion—Cisplatin—bone cancer	0.0126	0.0126	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.0123	0.0123	CcSEcCtD
Betahistine—Discomfort—Cisplatin—bone cancer	0.0122	0.0122	CcSEcCtD
Betahistine—Anaphylactic shock—Cisplatin—bone cancer	0.0118	0.0118	CcSEcCtD
Betahistine—Nervous system disorder—Cisplatin—bone cancer	0.0116	0.0116	CcSEcCtD
Betahistine—Tachycardia—Cisplatin—bone cancer	0.0116	0.0116	CcSEcCtD
Betahistine—Skin disorder—Cisplatin—bone cancer	0.0115	0.0115	CcSEcCtD
Betahistine—Asthma—Methotrexate—bone cancer	0.0114	0.0114	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—bone cancer	0.0113	0.0113	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—bone cancer	0.0113	0.0113	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Betahistine—Asthma—Epirubicin—bone cancer	0.0107	0.0107	CcSEcCtD
Betahistine—Dyspnoea—Cisplatin—bone cancer	0.0106	0.0106	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Betahistine—Gastrointestinal disorder—Cisplatin—bone cancer	0.0102	0.0102	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.0101	0.0101	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—bone cancer	0.00997	0.00997	CcSEcCtD
Betahistine—Asthma—Doxorubicin—bone cancer	0.0099	0.0099	CcSEcCtD
Betahistine—Feeling abnormal—Cisplatin—bone cancer	0.00976	0.00976	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00946	0.00946	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00875	0.00875	CcSEcCtD
Betahistine—Hypersensitivity—Cisplatin—bone cancer	0.00873	0.00873	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—bone cancer	0.00865	0.00865	CcSEcCtD
Betahistine—Asthenia—Cisplatin—bone cancer	0.0085	0.0085	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—bone cancer	0.00826	0.00826	CcSEcCtD
Betahistine—Diarrhoea—Cisplatin—bone cancer	0.00811	0.00811	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—bone cancer	0.0081	0.0081	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—bone cancer	0.00773	0.00773	CcSEcCtD
Betahistine—Vomiting—Cisplatin—bone cancer	0.00753	0.00753	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—bone cancer	0.00749	0.00749	CcSEcCtD
Betahistine—Rash—Cisplatin—bone cancer	0.00747	0.00747	CcSEcCtD
Betahistine—Dermatitis—Cisplatin—bone cancer	0.00746	0.00746	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—bone cancer	0.00739	0.00739	CcSEcCtD
Betahistine—Flatulence—Epirubicin—bone cancer	0.00735	0.00735	CcSEcCtD
Betahistine—Malaise—Methotrexate—bone cancer	0.00718	0.00718	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—bone cancer	0.00716	0.00716	CcSEcCtD
Betahistine—Nausea—Cisplatin—bone cancer	0.00704	0.00704	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—bone cancer	0.00692	0.00692	CcSEcCtD
Betahistine—Convulsion—Methotrexate—bone cancer	0.0069	0.0069	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—bone cancer	0.0068	0.0068	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00673	0.00673	CcSEcCtD
Betahistine—Malaise—Epirubicin—bone cancer	0.00672	0.00672	CcSEcCtD
Betahistine—Discomfort—Methotrexate—bone cancer	0.0067	0.0067	CcSEcCtD
Betahistine—Confusional state—Methotrexate—bone cancer	0.00655	0.00655	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—bone cancer	0.0065	0.0065	CcSEcCtD
Betahistine—Convulsion—Epirubicin—bone cancer	0.00646	0.00646	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—bone cancer	0.0064	0.0064	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—bone cancer	0.00638	0.00638	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—bone cancer	0.00631	0.00631	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.0063	0.0063	CcSEcCtD
Betahistine—Discomfort—Epirubicin—bone cancer	0.00627	0.00627	CcSEcCtD
Betahistine—Malaise—Doxorubicin—bone cancer	0.00622	0.00622	CcSEcCtD
Betahistine—Confusional state—Epirubicin—bone cancer	0.00613	0.00613	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—bone cancer	0.00608	0.00608	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—bone cancer	0.00598	0.00598	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—bone cancer	0.00597	0.00597	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—bone cancer	0.00594	0.00594	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—bone cancer	0.00591	0.00591	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00583	0.00583	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—bone cancer	0.0058	0.0058	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—bone cancer	0.0058	0.0058	CcSEcCtD
Betahistine—Somnolence—Methotrexate—bone cancer	0.00578	0.00578	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—bone cancer	0.00572	0.00572	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—bone cancer	0.00568	0.00568	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—bone cancer	0.00563	0.00563	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00561	0.00561	CcSEcCtD
Betahistine—Fatigue—Methotrexate—bone cancer	0.0056	0.0056	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—bone cancer	0.00552	0.00552	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—bone cancer	0.00549	0.00549	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—bone cancer	0.00547	0.00547	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—bone cancer	0.00542	0.00542	CcSEcCtD
Betahistine—Somnolence—Epirubicin—bone cancer	0.00541	0.00541	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—bone cancer	0.00536	0.00536	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—bone cancer	0.00536	0.00536	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—bone cancer	0.00525	0.00525	CcSEcCtD
Betahistine—Fatigue—Epirubicin—bone cancer	0.00525	0.00525	CcSEcCtD
Betahistine—Urticaria—Methotrexate—bone cancer	0.00516	0.00516	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—bone cancer	0.00502	0.00502	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—bone cancer	0.005	0.005	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—bone cancer	0.00496	0.00496	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00486	0.00486	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—bone cancer	0.00485	0.00485	CcSEcCtD
Betahistine—Urticaria—Epirubicin—bone cancer	0.00483	0.00483	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—bone cancer	0.00479	0.00479	CcSEcCtD
Betahistine—Asthenia—Methotrexate—bone cancer	0.00466	0.00466	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—bone cancer	0.00464	0.00464	CcSEcCtD
Betahistine—Pruritus—Methotrexate—bone cancer	0.0046	0.0046	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—bone cancer	0.00448	0.00448	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—bone cancer	0.00447	0.00447	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—bone cancer	0.00445	0.00445	CcSEcCtD
Betahistine—Asthenia—Epirubicin—bone cancer	0.00436	0.00436	CcSEcCtD
Betahistine—Pruritus—Epirubicin—bone cancer	0.0043	0.0043	CcSEcCtD
Betahistine—Dizziness—Methotrexate—bone cancer	0.0043	0.0043	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—bone cancer	0.00416	0.00416	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—bone cancer	0.00415	0.00415	CcSEcCtD
Betahistine—Vomiting—Methotrexate—bone cancer	0.00413	0.00413	CcSEcCtD
Betahistine—Rash—Methotrexate—bone cancer	0.0041	0.0041	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—bone cancer	0.0041	0.0041	CcSEcCtD
Betahistine—Headache—Methotrexate—bone cancer	0.00407	0.00407	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—bone cancer	0.00404	0.00404	CcSEcCtD
Betahistine—Dizziness—Epirubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—bone cancer	0.00398	0.00398	CcSEcCtD
Betahistine—Vomiting—Epirubicin—bone cancer	0.00387	0.00387	CcSEcCtD
Betahistine—Nausea—Methotrexate—bone cancer	0.00386	0.00386	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—bone cancer	0.00385	0.00385	CcSEcCtD
Betahistine—Rash—Epirubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Betahistine—Headache—Epirubicin—bone cancer	0.00381	0.00381	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—bone cancer	0.00372	0.00372	CcSEcCtD
Betahistine—Nausea—Epirubicin—bone cancer	0.00361	0.00361	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—bone cancer	0.00358	0.00358	CcSEcCtD
Betahistine—Rash—Doxorubicin—bone cancer	0.00355	0.00355	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—bone cancer	0.00355	0.00355	CcSEcCtD
Betahistine—Headache—Doxorubicin—bone cancer	0.00353	0.00353	CcSEcCtD
Betahistine—Nausea—Doxorubicin—bone cancer	0.00334	0.00334	CcSEcCtD
